A friend in my running group mentioned she had switched to Retatrutide through a research supplier after hitting the same wall
Their website offers evidence-based information tailored to Canadian patients and healthcare contexts
Therapeutic potential of semaglutide, a newer GLP-1 receptor agonist, in abating obesity, non-alcoholic steatohepatitis and neurodegenerative diseases: a narrative review
Slower digestion means more time for gut bacteria to ferment food, which can produce gas, and more time for the colon to reabsorb water, which can make stool harder to pass
See FDA non-inspection-based WLs: Prodose, Inc
However, specialized sports anti-doping tests (like those administered by WADA or USADA) do test for GLP-1 receptor agonists and related compounds